See what we’re up to – and what we have to say – in today’s dynamic market.


Accelerating Development

Here we review how a Risk-Based Quality Management (RBQM) approach to trial oversight can overcome many of the challenges facing clinical trial sponsors today ─ delivering the highest quality data, study performance improvements, and significant cost savings throughout their clinical trials.

Read More

Therapeutic Innovation and Regulatory Science

Published on behalf of the ePRO Consortium, this article recommends a structured framework for training site personnel and study participants in order to optimize the advantages clinical trial sponsors can gain from using ePRO data collection systems.

Read More

Risk-based Quality Management: The New Normal

This article reviews how clinical trial sponsors who take a risk-based approach to trial planning, management, and oversight can improve data quality, protocol compliance, enrollment and retention, ultimately achieving significant clinical development cost and time savings.

Read More

Digital Technology Changing the Face of Clinical Research

This article presents the opinions of industry thought leaders – including ERT’s Chief Technology Officer, Don Ragas – on how clinical trial sponsors and CROs are leveraging technology solutions to address the clinical development challenges facing the industry today and in the future.

Read More

Assessing Cardiac Safety in Phase I

Learn how clinical trial sponsors who conduct QT assessments during Phase I can harness the power of early knowledge to better inform their development decisions while saving considerable time and money.

Read More

Imaging Innovations

Learn how a combination of advanced technology and effective site radiologist training enables sponsors to reduce error rates and ensure the highest quality data when imaging endpoints are used in oncology clinical trials.

Read More